SCYNEXIS, Inc. Operating Lease Right-of-Use Assets
SCYNEXIS, Inc. (SCYX) had Operating Lease Right-of-Use Assets of $1.58 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $1.58M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.67M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.76M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.85M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $1.58M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.67M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.76M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.85M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.93M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.01M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.09M 10-K · filed 2026-03-04 |
| 2024-09-30 | $2.16M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.23M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.30M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.36M 10-K · filed 2025-03-12 |
| 2023-09-30 | $2.42M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.48M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.54M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.59M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.65M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.70M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.75M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.80M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.85M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.90M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.95M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.00M 10-K · filed 2022-03-29 |
| 2020-09-30 | $3.05M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.09M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.14M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.19M 10-K · filed 2021-03-29 |
| 2019-09-30 | $3.24M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.28M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.32M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $3.37M 10-K · filed 2020-03-11 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |